| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Balcom Alexandra | Chief Financial Officer | C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE | /s/ Nathan N. McConarty, attorney-in-fact | 23 Dec 2025 | 0001862147 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVL | Class A Common Stock | Options Exercise | $37,260 | +34,500 | +63% | $1.08 | 89,150 | 22 Dec 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVL | Stock Option (Right to Buy) | Options Exercise | $0 | -34,500 | -18% | $0.000000 | 161,656 | 22 Dec 2025 | Class A Common Stock | 34,500 | $1.08 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The shares underlying this option are fully vested. |